---
document_datetime: 2025-01-30 09:34:15
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nexium-control-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: nexium-control-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.309882
conversion_datetime: 2025-12-24 08:24:25.368977
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nexium Control

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                   |
|----------------------|----------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/1269/ 202403   | Periodic Safety Update EU Single assessment - esomeprazole                 | 14/11/2024                          | 13/01/2025                                  | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/1269/202403. |
| IAIN/0043            | A.1 - Administrative change - Change in the name and/or address of the MAH | 04/12/2024                          |                                             | SmPC, Labelling and              |                                                                                                                                           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                    |                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |            | PL              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0042            | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                               | 30/09/2024 | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| N/0040             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                               | 19/03/2024 |            | PL              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| II/0038            | Submission of an updated RMP version 2.0 in order to update the list of safety concerns to meet the definition of important risk and missing information provided in GVP Module V Rev. 2 C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH | 06/07/2023 | n/a        |                 | The MAH updated the list of safety concerns in the risk management plan removing risks that are well known and do not require further characterisation via additional pharmacovigilance activities, are without impact on the benefit-risk profile and are monitored via routine pharmacovigilance activities namely through signal detection and adverse reaction reporting and are minimised via routine risk minimisation activities namely product labelling. |
| IAIN/0039          | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                                                                                                                     | 24/04/2023 | 27/03/2024 | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| N/0037             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                               | 10/01/2022 | 17/02/2022 | PL              |                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| PSUSA/1269/ 202103 | Periodic Safety Update EU Single assessment - esomeprazole                                                                                                                                                                                                                                                                                                                                                                                     | 28/10/2021 | n/a        |                 | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| IB/0035   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                             | 08/02/2021   | 17/02/2022   | SmPC, Labelling and PL   |                     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|---------------------|
| T/0033    | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                        | 13/10/2020   | 10/11/2020   | SmPC, Labelling and PL   |                     |
| IB/0032   | B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from manufacturer                                                                                                                                                                                                                                                                                        | 23/10/2020   | n/a          |                          | an already approved |
|           | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 10/06/2020   | 10/11/2020   | SmPC, Labelling and PL   | IB/0029/G           |
| IB/0031/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient B.I.a.1.z - Change in the manufacturer of AS or of a material/reagent/intermediate for AS - Other                                                          | 28/04/2020   | n/a          |                          | starting            |

<div style=\"page-break-after: always\"></div>

|           | variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |     |                              |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------|
| IB/0030/G | This was an application for a group of variations. B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.z - Change in the manufacturing process of product - Other variation | 31/03/2020 | n/a | the finished or intermediate |
| IA/0028   | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 02/10/2019 | n/a |                              |
| IA/0027   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 31/07/2019 | n/a |                              |
| IA/0026   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 18/01/2019 | n/a |                              |

<div style=\"page-break-after: always\"></div>

| IB/0025/G   | This was an application for a group of variations. B.II.d.1.g - Change in the specification parameters and/or limits of the finished product - Addition or replacement (excluding biological or immunological product) of a specification parameter wit its corresponding test method as a result of a safety or quality issue B.II.d.1.g - Change in the specification parameters and/or limits of the finished product - Addition or replacement (excluding biological or immunological product) of a specification parameter wit its corresponding test method as a result of a safety or quality issue   | 08/01/2019   | n/a        |                        |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|
| IB/0024     | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 05/12/2018   | 05/12/2019 | SmPC                   |
| T/0023      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 17/08/2018   | 28/09/2018 | SmPC, Labelling and PL |
| IB/0022/G   | This was an application for a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.1.e - Replacement or addition of a                                                                                                                                                                                                                                                                       | 05/07/2018   | n/a        |                        |

<div style=\"page-break-after: always\"></div>

|           | manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure   |            |            |                        |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|
| R/0021    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 26/04/2018 | 25/06/2018 | SmPC, Labelling and PL |
| IAIN/0020 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 21/11/2017 | n/a        |                        |

<div style=\"page-break-after: always\"></div>

|                    | site                                                                                                                                                                                                                  |            |            |                        |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IA/0019            | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State | 08/09/2017 | n/a        |                        |                                   |
| IB/0018            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                        | 29/08/2017 | 25/06/2018 | SmPC and PL            |                                   |
| X/0016             | Annex I_2.(d) Change or addition of a new pharmaceutical form                                                                                                                                                         | 21/04/2017 | 15/06/2017 | SmPC, Labelling and PL |                                   |
| IAIN/0017          | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                        | 27/10/2016 | 15/06/2017 | SmPC                   |                                   |
| PSUSA/1269/ 201603 | Periodic Safety Update EU Single assessment - esomeprazole                                                                                                                                                            | 27/10/2016 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0014            | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                        | 23/11/2015 | 26/05/2016 | SmPC and PL            |                                   |
| IA/0013            | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                      | 23/10/2015 | n/a        |                        |                                   |
| IA/0011            | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or                                                              | 13/08/2015 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|           | intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                           |            |            |                        |                                                      |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|------------------------------------------------------|
| IAIN/0010 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                            | 23/07/2015 | n/a        |                        |                                                      |
| N/0009    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                              | 10/07/2015 | 26/05/2016 | Labelling and PL       |                                                      |
| IAIN/0008 | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                    | 11/05/2015 | 26/05/2016 | Annex II and PL        |                                                      |
| IB/0007   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation | 08/01/2015 | n/a        |                        |                                                      |
| IAIN/0006 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                            | 04/12/2014 | n/a        |                        |                                                      |
| IB/0005   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                | 24/06/2014 | 27/05/2015 | SmPC, Labelling and PL |                                                      |
| T/0004    | Transfer of Marketing Authorisation from AstraZeneca AB to Pfizer Consumer Healthcare Ltd. Transfer of Marketing Authorisation                | 07/03/2014 | 21/03/2014 | SmPC, Labelling and PL |                                                      |
| II/0001   | C.I.z - Changes (Safety/Efficacy) of Human and                                                                                                | 23/01/2014 | 21/03/2014 | SmPC and               | The MAH summarised within this variation application |

<div style=\"page-break-after: always\"></div>

|             | Veterinary Medicinal Products - Other variation                                                                                                                                                                                                        |            |            | Labelling       | efficacy results of esomeprazole 20 mg from the pivotal trials on the treatment of symptoms of reflux including heartburn and acid regurgitation over a 24 hour period during the first two weeks of usage extracted from the Clinical Study Reports. This data as per agreed update to 5.1 of the SmPC was considered to be valuable information to healthcare professionals and consumers on the clinical benefits to be expected from the once daily dosing of this medicine, during the first two weeks of treatment. In accordance the outer package text was amended introducing temporary the statement 'new', the statements 'lasts 24 hours', a placeholder for a website and an adaptation of the indication statement in line with the SmPC.   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0003/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site | 25/11/2013 | n/a        |                 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IAIN/0002/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                    | 29/10/2013 | 21/03/2014 | Annex II and PL |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

| B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.2 - Change to importer, batch release arrangements and quality control testing of the FP - Including batch control/testing   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|